Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 24.00
0.00 (0.00%)
Jul 12, 2025, 4:41 AM CET
Safe Orthopaedics Revenue
In the year 2023, Safe Orthopaedics had annual revenue of 5.81M EUR, down -0.87%. Safe Orthopaedics had revenue of 2.61M in the half year ending June 30, 2024, with 23.80% growth.
Revenue
5.81M
Revenue Growth
+19.20%
P/S Ratio
0.04
Revenue / Employee
60.52K
Employees
96
Market Cap
218.94K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.81M | -51.00K | -0.87% |
| Dec 31, 2022 | 5.86M | 1.31M | 28.70% |
| Dec 31, 2021 | 4.55M | 896.00K | 24.49% |
| Dec 31, 2020 | 3.66M | -1.04M | -22.15% |
| Dec 31, 2019 | 4.70M | 1.23M | 35.38% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| Clariane SE | 5.28B |